Medications, such as Ozempic, Mounjaro, Wegovy, and more, have become increasingly popular for weight loss. These drugs are glucagon-like peptide 1 (GLP-1) receptor agonists, and they mimic a hormone that, among other things, tells the brain a person is full so they eat less. But are they safe, and do they help improve metabolic health? Dr. Rob Lustig and Dr. Casey Means discuss these weight-loss drugs and their effects on the body, and why such medications likely won’t solve the obesity crisis, for which the food industry is culpable.

Get Your Free Ultimate Guide to Glucose: https://levels.link/youtube?utm_campa...

📍What Rob Lustig, MD, & Casey Means, MD, discuss:
00:00 — Intro
06:24 — The mechanisms of action for weight-loss medications
09:07 — Dr. Casey Means shares her perception of the popularity of GLP-1 medications
13:19 — GLP-1 RAs lead to fat loss but also muscle loss
19:50 — Do GLP-1 RAs improve metabolic health?
22:29 — Dr. Lustig discusses the high cost of GLP-1 RAs
29:37 — Dr. Lustig makes the case for fixing the food problem
37:39 — How can patients use GLP-1 RAs as a jumpstart?
46:15 — Dr. Lustig shares his concerns about the use of GLP-1 RAs in children

👋 WHO WE ARE:

Levels helps you see how food affects your health. With real-time, personalized data gathered through biosensors like continuous glucose monitors (CGM), you learn which diet and lifestyle choices improve your metabolic health so you can live a longer, fuller, healthier life.

🔗 LINKS:
Transcripts & Show notes: https://www.levels.com/podcasts/226-h...
Robert Lustig, MD: https://robertlustig.com
Metabolical by Robert Lustig, MD: https://robertlustig.com/metabolical/

📲 CONNECT:

Subscribe here on YouTube:    / @levels  
Connect with Robert Lustig, MD, on Instagram:   / robertlustigmd  
Connect with Robert Lustig, MD, on Twitter:   / robertlustigmd  
Connect with Casey Means, MD, on Instagram:   / drcaseyskitchen  
Connect with Casey Means, MD, on Twitter:   / drcaseyskitchen